Additionally, we assessed NFIL3 protein expression using paraffin sections from 12 ovarian normal controls and 12 ovarian cancer samples (Figure 2B), and the immunohistochemical scores were assessed by three pathologists. This evidence concerns the gene NFIL3 and ovarian cancer.